Prevalence of vascular disease in metabolic syndrome using three proposed definitions
Loading...
Date
Authors
Athyros, V. G.
Ganotakis, E. S.
Elisaf, M. S.
Liberopoulos, E. N.
Goudevenos, I. A.
Karagiannis, A.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Int J Cardiol
Book name
Book series
Book edition
Alternative title / Subtitle
Description
BACKGROUND: There are a number of definitions available for the diagnosis of the metabolic syndrome (MetS). The MetS-associated increase in cardiovascular disease (CVD) risk may depend on the definition used. AIM: To investigate which of the 3 recently proposed definitions of MetS [the National Cholesterol Education Program-Adult Treatment Panel-III (NCEP-ATP-III), the International Diabetes Federation (IDF) and the American Heart Association/National Heart Lung and Blood Institute (AHA/NHLBI)] is related to excessive CVD risk and thus may be more appropriate to implement in clinical practice. METHODS: A cross-sectional analysis of a representative sample of Greek adults (n=9669). RESULTS: The age-adjusted CVD prevalence was 11.4% in the whole study population, 23.3% in the NCEP-ATP-III (+) subjects, 22.6% in AHA/NHLBI (+) subjects and 18.3% in IDF (+) subjects [p<0.001 for the comparison between the whole study population and all MetS groups and p<0.0001 for the comparison between IDF (+) and either NCEP-ATP-III (+) or AHA/NHLBI (+) MetS]. However, the CVD prevalence was only 11.2% in the IDF (+) but NCEP-ATP-III (-)/AHA/NHLBI (-) MetS subjects [p<0.0001 vs. either NCEP-ATP-III (+) or AHA/NHLBI (+)], which was not different compared with the whole study population. Furthermore, subjects with NCEP ATP III (+) or AHA/NHLBI (+) MetS but not diabetes (DM) had a persistently higher prevalence of CVD compared with the whole study population. However, there was no significant difference regarding CVD prevalence between the whole study population and IDF (+)/DM (-) MetS subjects. CONCLUSIONS: CVD prevalence was increased in the presence of MetS irrespective of the definition used. However, this increase was more pronounced when the NCEP-ATP-III and AHA/NHLBI criteria were implemented compared with the IDF definition. Furthermore, the IDF definition included a large proportion of subjects who did not have increased CVD prevalence compared with the whole study population. These findings may have implications regarding which definition should we use to diagnose the MetS.
Description
Keywords
Adult, Aged, Cardiovascular Diseases/*epidemiology, Cross-Sectional Studies, Female, Greece/epidemiology, Humans, International Classification of Diseases, Male, Metabolic Syndrome X/*classification/*epidemiology, Middle Aged, Prevalence, Risk Factors
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/16854482
http://ac.els-cdn.com/S016752730600547X/1-s2.0-S016752730600547X-main.pdf?_tid=2f1ece1701a09cb2f0dd70f426984622&acdnat=1333966179_d2e3fda81c9bc1e4f40d58d4977aed07
http://ac.els-cdn.com/S016752730600547X/1-s2.0-S016752730600547X-main.pdf?_tid=2f1ece1701a09cb2f0dd70f426984622&acdnat=1333966179_d2e3fda81c9bc1e4f40d58d4977aed07
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής